Tolnaftate

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Tolnaftate
Generic name: TOLNAFTATE
Manufacturer: NuCare Pharmaceuticals,Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 63665de7-8415-651f-e053-2991aa0ac2bb
SPL ID: 1a3c5c49-b376-1318-e063-6394a90a47b6
Version: 4
Effective date: 2024-06-06
Source export date: 2026-10-12
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:09:54

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M014	openfda.application_number
brand name		Tolnaftate	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		NuCare Pharmaceuticals,Inc.	openfda.manufacturer_name
ndc	package	68071-4245-5	openfda.package_ndc
ndc	product	68071-4245	openfda.product_ndc
ndc11	package	68071424505	derived:openfda.package_ndc
rxcui		103951	openfda.rxcui
spl id		1a3c5c49-b376-1318-e063-6394a90a47b6	id
spl set id		63665de7-8415-651f-e053-2991aa0ac2bb	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use on children under 2 years of age unless directed by a doctor When using this product avoid contact with eyes Stop use and ask a doctor if irritation occurs or if there is no improvement within 4 weeks (for athlete's foot and ringworm) irritation occurs or if there is no improvement within 2 weeks (for jock itch) Keep this and all drugs out of the reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.